Kiora Pharmaceuticals
KPRX
KPRX
15 hedge funds and large institutions have $160K invested in Kiora Pharmaceuticals in 2023 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
0.19% more ownership
Funds ownership: 0.25% → 0.44% (+0.19%)
Holders
15
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$49.1K | |
| 2 | +$15K | |
| 3 | +$10K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$7.35K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$389 |
Top Sellers
| 1 | -$6.94K | |
| 2 | -$27 | |
| 3 | -$5 | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$1 |